FDA
approval
· 2024-05-17
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for the combination product amlodipine and atorvastatin from Prasco Laboratories, enabling its continued/expanded use un…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)